Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Astellas Pharma Gross Profit 2012-2023 | ALPMY

Astellas Pharma annual/quarterly gross profit history and growth rate from 2012 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Astellas Pharma gross profit for the quarter ending December 31, 2023 was $M, a 100% decline year-over-year.
  • Astellas Pharma gross profit for the twelve months ending December 31, 2023 was $6.891B, a 25.63% decline year-over-year.
  • Astellas Pharma annual gross profit for 2023 was $9.25B, a 8.19% increase from 2022.
  • Astellas Pharma annual gross profit for 2022 was $8.55B, a 5.42% decline from 2021.
  • Astellas Pharma annual gross profit for 2021 was $9.04B, a 3.78% decline from 2020.
  
Astellas Pharma Annual Gross Profit
(Millions of US $)
2023 $9,250
2022 $8,550
2021 $9,040
2020 $9,395
2019 $9,138
2018 $9,491
2017 $8,849
2016 $8,608
2015 $8,318
2014 $7,857
2013 $7,250
2012 $7,936
2011 $11,791
2010 $10,519
2009 $
Astellas Pharma Quarterly Gross Profit
(Millions of US $)
2023-12-31
2023-06-30 $2,234
2022-06-30 $2,255
2021-06-30 $2,402
2020-06-30 $2,300
2019-06-30 $2,399
2018-06-30 $2,377
2017-06-30 $2,190
2016-09-30 $2,344
2016-06-30 $2,476
2016-03-31 $2,088
2015-12-31 $2,264
2015-09-30 $2,177
2015-06-30 $2,079
2015-03-31 $1,825
2014-12-31 $2,270
2014-09-30 $2,076
2014-06-30 $2,148
2014-03-31
2013-12-31
2013-09-30
2013-06-30 $1,911
2013-03-31
2012-12-31
2012-09-30
2012-06-30 $2,122
2012-03-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $17.771B $11.108B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.648B 31.17
Chugai Pharmaceutical (CHGCY) Japan $57.871B 25.87
Takeda Pharmaceutical (TAK) Japan $41.080B 8.32
Merck (MKGAF) Germany $21.118B 20.48
Sandoz Group AG (SDZNY) Switzerland $15.585B 0.00
United Therapeutics (UTHR) United States $14.151B 15.09
Neurocrine Biosciences (NBIX) United States $13.594B 37.21
Shionogi (SGIOY) Japan $11.423B 9.93
Catalent (CTLT) United States $10.160B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.208B 0.00
Ionis Pharmaceuticals (IONS) United States $6.860B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.816B 7.49
Revolution Medicines (RVMD) United States $6.406B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Madrigal Pharmaceuticals (MDGL) United States $5.968B 0.00
Summit Therapeutics (SMMT) United States $5.623B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.538B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.337B 0.00
Corcept Therapeutics (CORT) United States $3.164B 28.67
Dyne Therapeutics (DYN) United States $2.963B 0.00
PTC Therapeutics (PTCT) United States $2.696B 0.00
Indivior (INDV) United States $2.245B 10.64
Recursion Pharmaceuticals (RXRX) United States $2.229B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.006B 11.40
Catalyst Pharmaceuticals (CPRX) United States $1.789B 17.41
NewAmsterdam Pharma (NAMS) Netherlands $1.770B 0.00
Evotec AG (EVO) Germany $1.673B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.615B 24.28
Ardelyx (ARDX) United States $1.401B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.374B 0.00
Pacira BioSciences (PCRX) United States $1.321B 12.56
Soleno Therapeutics (SLNO) United States $1.301B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.255B 0.00
Xencor (XNCR) United States $1.193B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.157B 0.00
4D Molecular Therapeutics (FDMT) United States $1.137B 0.00
Collegium Pharmaceutical (COLL) United States $1.031B 6.17
Ocular Therapeutix (OCUL) United States $1.016B 0.00
Enliven Therapeutics (ELVN) United States $1.010B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.966B 15.05
Cassava Sciences (SAVA) United States $0.925B 0.00
Relay Therapeutics (RLAY) United States $0.895B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.893B 0.00
Cronos Group (CRON) Canada $0.867B 0.00
USANA Health Sciences (USNA) United States $0.849B 13.89
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.795B 0.00
Harrow (HROW) United States $0.766B 0.00
ARS Pharmaceuticals (SPRY) United States $0.741B 0.00
Sage Therapeutics (SAGE) United States $0.656B 0.00
Exscientia (EXAI) United Kingdom $0.639B 0.00
Silence Therapeutics (SLN) United Kingdom $0.597B 0.00
Lexeo Therapeutics (LXEO) United States $0.556B 0.00
Altimmune (ALT) United States $0.525B 0.00
Savara (SVRA) United States $0.525B 0.00
Siga Technologies (SIGA) United States $0.524B 6.70
Lyell Immunopharma (LYEL) United States $0.520B 0.00
ProKidney (PROK) United States $0.511B 0.00
KalVista Pharmaceuticals (KALV) United States $0.487B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.474B 0.00
Heron Therapeutics (HRTX) United States $0.459B 0.00
Larimar Therapeutics (LRMR) United States $0.449B 0.00
OmniAb (OABI) United States $0.446B 0.00
Verve Therapeutics (VERV) United States $0.439B 0.00
Bioventus (BVS) United States $0.434B 16.61
Theravance Biopharma (TBPH) Cayman Islands $0.409B 0.00
Esperion Therapeutics (ESPR) United States $0.396B 0.00
Tourmaline Bio (TRML) United States $0.364B 0.00
Organogenesis (ORGO) United States $0.331B 62.50
Xeris Biopharma Holdings (XERS) United States $0.311B 0.00
Korro Bio (KRRO) United States $0.310B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.299B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 17.86
Black Diamond Therapeutics (BDTX) United States $0.264B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.259B 0.00
Nanobiotix S.A (NBTX) France $0.230B 0.00
Foghorn Therapeutics (FHTX) United States $0.223B 0.00
Century Therapeutics (IPSC) United States $0.216B 0.00
ESSA Pharma (EPIX) Canada $0.215B 0.00
Incannex Healthcare (IXHL) Australia $0.214B 0.00
Eliem Therapeutics (ELYM) United States $0.213B 0.00
Aquestive Therapeutics (AQST) United States $0.210B 0.00
Prelude Therapeutics (PRLD) United States $0.208B 0.00
Fractyl Health (GUTS) United States $0.207B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
Avita Medical (RCEL) United States $0.205B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Aldeyra Therapeutics (ALDX) United States $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.197B 0.00
Elite Pharmaceuticals (ELTP) United States $0.195B 18.28
Zevra Therapeutics (ZVRA) United States $0.192B 0.00
Acrivon Therapeutics (ACRV) United States $0.187B 0.00
Pyxis Oncology (PYXS) United States $0.180B 0.00
Akebia Therapeutics (AKBA) United States $0.180B 0.00
Adherex Technologies (FENC) United States $0.169B 206.67
Context Therapeutics (CNTX) United States $0.164B 0.00
Achieve Life Sciences (ACHV) Canada $0.159B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.148B 0.00
Cardiol Therapeutics (CRDL) Canada $0.146B 0.00
Regulus Therapeutics (RGLS) United States $0.140B 0.00
Metagenomi (MGX) United States $0.140B 0.00
Galectin Therapeutics (GALT) United States $0.139B 0.00
CytoDyn (CYDY) United States $0.137B 0.00
Karyopharm Therapeutics (KPTI) United States $0.136B 0.00
MediWound (MDWD) Israel $0.136B 0.00
Telomir Pharmaceuticals (TELO) United States $0.133B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.126B 8.41
VAXART, INC (VXRT) United States $0.122B 0.00
Citius Pharmaceuticals (CTXR) United States $0.121B 0.00
OptiNose (OPTN) United States $0.116B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Assertio Holdings (ASRT) United States $0.114B 5.22
Journey Medical (DERM) United States $0.100B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
Conduit Pharmaceuticals (CDT) United States $0.091B 0.00
Relmada Therapeutics (RLMD) United States $0.090B 0.00
AlloVir (ALVR) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.086B 0.00
ProPhase Labs (PRPH) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.071B 1.01
Vivani Medical (VANI) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Nutriband (NTRB) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.055B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
CASI Pharmaceuticals (CASI) China $0.049B 0.00
Carisma Therapeutics (CARM) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Tempest Therapeutics (TPST) United States $0.046B 0.00
Inotiv (NOTV) United States $0.045B 0.00
DURECT (DRRX) United States $0.044B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Protara Therapeutics (TARA) United States $0.043B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Surrozen (SRZN) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
BioVie (BIVI) United States $0.027B 0.00
VYNE Therapeutics (VYNE) United States $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.025B 0.00
SHINECO (SISI) China $0.024B 0.00
Gain Therapeutics (GANX) United States $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Viracta Therapeutics (VIRX) United States $0.022B 0.00
Minerva Neurosciences (NERV) United States $0.022B 0.00
GlycoMimetics (GLYC) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Iterum Therapeutics (ITRM) Ireland $0.020B 0.00
JanOne (JAN) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.73
Unicycive Therapeutics (UNCY) United States $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.019B 0.00
PolyPid (PYPD) Israel $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Talphera (TLPH) United States $0.014B 0.00
Mannatech (MTEX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.011B 0.00
Alaunos Therapeutics (TCRT) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Molecular Templates (MTEM) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.05
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 29.19